United States
I am an incoming PhD student at Rutgers University, with a focus on using experimental and computational approaches to study disease mechanisms and therapeutically actionable targets. I graduate from Cornell University studying Biological Sciences, where I concentrated in Computational Biology and minored in Data Science. My research interests span cancer biology, functional genomics, computational structural biology, and drug discovery. I have experience across academic and biotech research settings, including cancer signaling, proteomics, CRISPR-based approaches, mutagenesis screens, AlphaFold-based modeling, RFdiffusion, ProteinMPNN, protein–protein and protein–metabolite interaction analysis, and molecular docking.
Conducted research in the Xiaoyang Wu Lab on epidermolysis bullosa, skin grafting, and regenerative biology. Contributed to gel-based grafting models, mutagenesis screens, and molecular analyses to study disease-relevant phenotypes and tissue repair mechanisms.
Performed computational structural biology analyses for an early-stage therapeutics startup, focusing on protein–protein and protein–metabolite interactions. Applied AlphaFold modeling, RFdiffusion, ProteinMPNN, interface analysis, and docking workflows to prioritize structurally actionable targets and support investor-facing scientific strategy.
Studied cancer signaling and protein stability in the Roberts Lab at Dana-Farber Cancer Institute. Contributed to research on PyST-mediated TAZ degradation using CRISPR-based perturbation, proteomics-based analysis, and molecular biology workflows to investigate Hippo pathway regulation and oncogenic transcriptional control.
Studied signaling vulnerabilities in PTEN-deficient breast cancer models at Dana-Farber Cancer Institute Zhao Lab. Contributed to molecular biology experiments evaluating PI3Kβ and FGFR1 pathway interactions, with a focus on cancer signaling, therapeutic response, and biomarker-relevant mechanisms.
Studied immunological mechanisms involved in glaucoma and optic nerve degeneration at Schepens Eye Research Institute / Mass Eye and Ear Chen Lab. Contributed to research on microglial activation, inflammatory signaling, and candidate protein regulators of neurodegeneration in ocular disease models.